

L-Threo-methylphenidate (CAS 20748-11-2) remains a critical component in the U.S. API intermediates market, where its role in the synthesis of specialized central nervous system stimulants requires a Pharma/API purity 99% to satisfy rigorous FDA compliance and American Chemical Society standards. Methyl (2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetate serves as a high purity fine chemical for North American CDMOs who are increasingly seeking custom synthesis services to build domestic supply chain resilience against global sourcing shifts. L-threo-Methylphenidate hydrochloride is also utilized in advanced neuro-pharmacological research and controlled industrial applications at a General Industry purity 98%, driving demand for a reliable bulk chemical supplier capable of navigating the complex regulatory landscape of the United States. We are an established L-Threo-methylphenidate intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting L-Threo-methylphenidate COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities


L-Threo-methylphenidate (CAS 20748-11-2) remains a critical component in the U.S. API intermediates market, where its role in the synthesis of specialized central nervous system stimulants requires a Pharma/API purity 99% to satisfy rigorous FDA compliance and American Chemical Society standards. Methyl (2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetate serves as a high purity fine chemical for North American CDMOs who are increasingly seeking custom synthesis services to build domestic supply chain resilience against global sourcing shifts. L-threo-Methylphenidate hydrochloride is also utilized in advanced neuro-pharmacological research and controlled industrial applications at a General Industry...
Pharmaceutical
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png)

Chemical Properties & Specifications
P264, P270, P301+P317, P330, and P501
Acute Tox. 4 (100%)
A high-purity chiral building block and analytical reference standard used in forensic toxicology and biochemical research to investigate the enantioselective pharmacokinetics and pharmacodynamics of methylphenidate
A specialized isomer used in the development and study of central nervous system stimulants for treating attention-deficit hyperactivity disorder (ADHD) and narcolepsy.
L-Threo-methylphenidate is a psychostimulant and a central nervous system stimulant primarily used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy by inhibiting the reuptake of dopamine and norepinephrine
This compound is predominantly used in the pharmaceutical and medical industries for clinical treatments, as well as in forensics and biological research
It is commonly formulated as oral tablets, capsules (immediate, extended, or sustained release), orally disintegrating tablets, and transdermal patches
Standard specifications include CAS number 29419-95-2, a molecular weight of 269.77, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...